These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Halothane hepatitis: a critical review. Carney FM, Van Dyke RA. Anesth Analg; 1972 Dec 23; 51(1):135-60. PubMed ID: 4399967 [No Abstract] [Full Text] [Related]
51. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes. Kawamoto M, Fujii K, Yuge O, Morio M. Hiroshima J Med Sci; 1989 Dec 23; 38(4):161-7. PubMed ID: 2637243 [Abstract] [Full Text] [Related]
53. Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane. Walton B, Hamblin A, Dumonde DC, Simpson R. Anesthesiology; 1976 May 23; 44(5):391-7. PubMed ID: 1267204 [Abstract] [Full Text] [Related]
57. [Current status of the problem of halothane hepatotoxicity]. Karlinskiĭ MV. Anesteziol Reanimatol; 1987 May 23; (3):70-5. PubMed ID: 3307542 [No Abstract] [Full Text] [Related]
58. Midzonal liver necrosis associated with fluorinated anesthetic agents. Haber MH, Lau JM. Hawaii Med J; 1973 May 23; 32(1):18-20. PubMed ID: 4734691 [No Abstract] [Full Text] [Related]
59. [Toxic hepatic lesions after gastrectomy with fluothane anesthesia]. Bogdan F, Ispas M, Oprişor M. Rev Med Chir Soc Med Nat Iasi; 1968 May 23; 72(2):455-8. PubMed ID: 5677772 [No Abstract] [Full Text] [Related]